References
- 1. F. P. Schmidtchen and M. Berger, Artificial organic host molecules for anions, Chem. Rev.97 (1997) 1609–1646; DOI: 10.1021/cr9603845.
- 2. U. E. W. Lange, D. Baucke, W. Hornberger, H. Mack, W. Seitz and H. W. Höffken, D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety, Bioorg. Med. Chem. Lett.13 (2003) 2029–2033; DOI: 10.1016/S0960-894X(03)00347-0.
- 3. J. L. Jiménez Blanco, P. Bootello, J. M. Benito, C. O. Mellet and J. M. García Fernandez, Urea-, thiourea-, and guanidine-linked glycooligomers as phosphate binders in water, J. Org. Chem.71 (2006) 5136–5143; DOI: 10.1021/jo060360q.
- 4. S. Ekelund, P. Nygren and R. Larsson, Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology, Biochem. Pharmacol.61 (2001) 1183–1193; DOI: 10.1016/S0006-2952(01)00570-6.
- 5. A. Andreani, M. Granaiola, A. Leoni, A. Locatelli, R. Morigi, M. Rambaldi, G. Lenaz, R. Fato, C. Bergamini and G. Farruggia, Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2’,3’:2,3]imidazo[4,5-c]quinoline, J. Med. Chem.48 (2005) 3085–3089; DOI: 10.1021/jm040888s.
- 6. A. L. LaFrate, J. R. Gunther, K. E. Carlson and J. A. Katzenellenbogen, Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor, Bioorg. Med. Chem.16 (2008) 10075–10084; DOI: 10.1016/j.bmc.2008.10.007.
- 7. P. Ulrich and A. Cerami, Trypanocidal 1,3-arylene diketone bis(guanylhydrazone)s. Structure-activity relationships among substituted and heterocyclic analogues, J. Med. Chem.27 (1984) 35–40; DOI: 10.1021/jm00367a007.
- 8. J. R. Ring, F. Zheng, A. J. Haubner, J. M. Littleton and P. A Crooks, Improving the inhibitory activity of arylidenaminoguanidine compounds at the N-methyl-D-aspartate receptor complex from a recursive computational-experimental structure-activity relationship study, Bioorg. Med. Chem.21 (2013) 1764–1774; DOI: 10.1016/j.bmc.2013.01.051.